PI3K-Activated MSC Proteomes Inhibit Mammary Tumors via Hsp90ab1 and Myh9

In an ex vivo assay, the size of freshly isolated human breast cancer tissues, including ER-positive & negative as well as HER2-positive & negative, was reduced by YS49-treated mesenchymal stem cell (MSC) derived conditioned medium.